Search research articles
Contact Us
Filters
Showing results (71-80 of 118) with videos related to
Page
of 12
Sort By:
Biomaterials
|
February 12, 2021
A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death
Haozhe Huang, Yixian Huang, Yuang Chen, et al.
Acta Biomaterialia
|
February 1, 2020
Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy
Jingjing Sun, Zhuoya Wan, Yichao Chen, et al.
Cancer Immunology Research
|
September 12, 2020
Tumor-Derived IL33 Promotes Tissue-Resident CD8<sup>+</sup> T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy
Lujun Chen, Runzi Sun, Junchi Xu, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2019
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Cell Death & Disease
|
April 17, 2026
Dedifferentiation-driven oncogenic stemness promotes tumor-sustaining adaptability in the intestinal epithelium
Kylee Zgeib, Thompson Hui, Simon Garcia, et al.
Oncoimmunology
|
February 21, 2020
Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment
Min Yang, Wenwen Du, Lixian Yi, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2021
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
Min Yang, Esther Giehl, Chao Feng, et al.
Nature Communications
|
November 8, 2016
An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
Yichao Chen, Rui Xia, Yixian Huang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 11, 2023
Loss of Protein Kinase D2 Activity Protects Against Bleomycin-Induced Dermal Fibrosis in Mice
Liping Chen, Jinjun Zhao, Yapeng Chao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2016
PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor
Liangrong Shi, Lujun Chen, Changping Wu, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 118) with videos related to
Sort By:
Page
of 12
Biomaterials
|
February 12, 2021
A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death
Haozhe Huang, Yixian Huang, Yuang Chen, et al.
Acta Biomaterialia
|
February 1, 2020
Triple drugs co-delivered by a small gemcitabine-based carrier for pancreatic cancer immunochemotherapy
Jingjing Sun, Zhuoya Wan, Yichao Chen, et al.
Cancer Immunology Research
|
September 12, 2020
Tumor-Derived IL33 Promotes Tissue-Resident CD8<sup>+</sup> T Cells and Is Required for Checkpoint Blockade Tumor Immunotherapy
Lujun Chen, Runzi Sun, Junchi Xu, et al.
Journal for Immunotherapy of Cancer
|
January 11, 2019
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics
Zong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Cell Death & Disease
|
April 17, 2026
Dedifferentiation-driven oncogenic stemness promotes tumor-sustaining adaptability in the intestinal epithelium
Kylee Zgeib, Thompson Hui, Simon Garcia, et al.
Oncoimmunology
|
February 21, 2020
Checkpoint molecules coordinately restrain hyperactivated effector T cells in the tumor microenvironment
Min Yang, Wenwen Du, Lixian Yi, et al.
Cancer Immunology, Immunotherapy : CII
|
February 4, 2021
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity
Min Yang, Esther Giehl, Chao Feng, et al.
Nature Communications
|
November 8, 2016
An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy
Yichao Chen, Rui Xia, Yixian Huang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
April 11, 2023
Loss of Protein Kinase D2 Activity Protects Against Bleomycin-Induced Dermal Fibrosis in Mice
Liping Chen, Jinjun Zhao, Yapeng Chao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2016
PD-1 Blockade Boosts Radiofrequency Ablation-Elicited Adaptive Immune Responses against Tumor
Liangrong Shi, Lujun Chen, Changping Wu, et al.
Page
of 12